COVID-19 asylum limits at US-Mexico border to end May 23

The Centers for Disease Control says it's ending a policy that limited asylum at the U.S.-Mexico border to prevent the spread of COVID-19

Biden
Biden

The Centers for Disease Control announced Friday that it is ending a policy that limited asylum at the U.S.-Mexico border to prevent the spread of COVID-19.

The use of public health powers had been widely criticized by Democrats and immigration advocates as an excuse for the United States to shirk its obligations to provide haven to people fleeing persecution. The policy went into effect under President Donald Trump in March 2020. Since then, migrants trying to enter the U.S. have been turned away more than 1.7 million times.

The policy, known as the Title 42 authority, named for a 1944 public health law to prevent communicable disease, will end on paper April 1, but it will not take effect until May 23, to allow border officials time to prepare.

“After considering current public health conditions and an increased availability of tools to fight COVID-19 (such as highly effective vaccines and therapeutics), the CDC director has determined that an order suspending the right to introduce migrants into the United States is no longer necessary,” the CDC said in a statement.

The decision is expected to draw more migrants to the U.S.-Mexico border.

The Department of Homeland Security said this week that about 7,100 migrants were coming daily, compared with an average of about 5,900 a day in February — on pace to match or exceed highs from last year, 2019 and other peak periods. But border officials said they are planning for as many as 18,000 arrivals daily.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in